KRAS mutant-specific protein interactions reveal mechanisms in pancreatic cancer tumorigenesis and metabolic regulation.

被引：0
|
作者：
Hobbs, Guy Aaron [1 ]
Burge, Rachel [1 ]
Linke, Amanda [1 ]
Sundararaj, Kamala [1 ]
O'Bryan, John P. [1 ]
机构：
[1] Med Univ South Carolina, Charleston, SC USA
来源：
CANCER RESEARCH | 2022年 / 82卷 / 22期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
B057
引用
收藏
页码：96 / 97
页数：2
相关论文
共 35 条
  • [31] SLC25A22 DRIVES IMMUNE SUPPRESSION IN KRAS-MUTANT COLORECTAL CANCER VIA METABOLIC REGULATION OF CXCL1/CXCR2 AXIS
    Zhou, Qiming
    Peng, Yao
    Chan, Lam-Shing
    Chen, Huarong
    Kang, Wei
    Nie, Yuqiang
    Yu, Jun
    Wong, Chi Chun
    GASTROENTEROLOGY, 2021, 160 (06) : S621 - S621
  • [32] LKB1 regulates BH3-mimetics vulnerability of KRAS mutant non-small cell lung cancer by alternating mitochondrial apoptotic protein interactions
    Li, Chendi
    Oh, Audris
    Nangia, Varuna
    Hata, Aaron N.
    CANCER RESEARCH, 2019, 79 (13)
  • [33] Transcriptional Regulation of Claudin-18 via Specific Protein Kinase C Signaling Pathways and Modification of DNA Methylation in Human Pancreatic Cancer Cells
    Ito, Tatsuya
    Kojima, Takashi
    Yamaguchi, Hiroshi
    Kyuno, Daisuke
    Kimura, Yasutoshi
    Imamura, Masafumi
    Takasawa, Akira
    Murata, Masaki
    Tanaka, Satoshi
    Hirata, Koichi
    Sawada, Norimasa
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2011, 112 (07) : 1761 - 1772
  • [34] Dissecting Molecular Principles of the Hsp90 Chaperone Regulation by Allosteric Modulators Using a Hierarchical Simulation Approach and Network Modeling of Allosteric Interactions: Conformational Selection Dictates the Diversity of Protein Responses and Ligand-Specific Functional Mechanisms
    Astl, Lindy
    Stetz, Gabrielle
    Verkhivker, Gennady M.
    JOURNAL OF CHEMICAL THEORY AND COMPUTATION, 2020, 16 (10) : 6656 - 6677
  • [35] Preliminary results from ERAS-007 plus palbociclib (palbo) in patients (pts) with KRAS/NRAS mutant (m) colorectal cancer (CRC) or KRASm pancreatic ductal adenocarcinoma (PDAC) in HERKULES-3 study: A phase 1b/2 study of agents targeting the mitogen-activated protein kinase (MAPK) pathway in pts with advanced gastrointestinal malignancies (GI cancers)
    Ulahannan, Susanna Varkey
    Spigel, David R.
    Lee, Michael Sangmin
    Fakih, Marwan
    Grierson, Patrick
    Christenson, Eric
    Chiorean, E. Gabriela
    Alan, Darryl
    Khan, Outlaw Gazala
    Atreya, Chloe Evelyn
    Parikh, Aparna Raj
    Dayyani, Farshid
    Spira, Alexander I.
    Kopetz, Scott
    Bullock, Andrea J.
    Li, Zhengrong
    Chen, Xiaoying
    Patel, Hina
    Hazra, Saswati
    Strickler, John H.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
1234